HK1220699A1 - 治療神經退行性蛋白質病的化合物 - Google Patents
治療神經退行性蛋白質病的化合物Info
- Publication number
- HK1220699A1 HK1220699A1 HK16108680.0A HK16108680A HK1220699A1 HK 1220699 A1 HK1220699 A1 HK 1220699A1 HK 16108680 A HK16108680 A HK 16108680A HK 1220699 A1 HK1220699 A1 HK 1220699A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compunds
- treating neurodegenerative
- neurodegenerative proteinopathies
- proteinopathies
- treating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/32—Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C07K2319/43—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361802184P | 2013-03-15 | 2013-03-15 | |
PCT/US2014/029202 WO2014144686A1 (en) | 2013-03-15 | 2014-03-14 | Compunds for treating neurodegenerative proteinopathies |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1220699A1 true HK1220699A1 (zh) | 2017-05-12 |
Family
ID=51537756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16108680.0A HK1220699A1 (zh) | 2013-03-15 | 2016-07-20 | 治療神經退行性蛋白質病的化合物 |
Country Status (7)
Country | Link |
---|---|
US (2) | US10030067B2 (zh) |
EP (1) | EP2970428A4 (zh) |
JP (1) | JP2016516053A (zh) |
AU (1) | AU2014228886B2 (zh) |
CA (1) | CA2942514A1 (zh) |
HK (1) | HK1220699A1 (zh) |
WO (1) | WO2014144686A1 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10030067B2 (en) | 2013-03-15 | 2018-07-24 | University Of Florida Research Foundation, Incorporated | Compounds for treating neurodegenerative proteinopathies |
KR102176284B1 (ko) * | 2015-04-08 | 2020-11-09 | 삼성전기주식회사 | 디지털 촬영시스템 및 그 제어방법 |
US10230888B2 (en) * | 2015-07-31 | 2019-03-12 | Qualcomm Incorporated | Sensor-based camera initialization |
KR20200134212A (ko) * | 2018-01-02 | 2020-12-01 | 러쉬 유니버시티 메디컬 센터 | 신경계 장애 및 기타 장애를 치료하기 위한 조성물 및 방법 |
CN114901275A (zh) | 2019-12-20 | 2022-08-12 | 纳米医疗有限公司 | 可用于治疗癌症的含有Toll样受体(“TLR”)激动剂前药的配制和/或共同配制的脂质体组合物及其方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1288226A1 (en) * | 2001-09-03 | 2003-03-05 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Modification of the expression levels of Toll-like receptor familiy members for influencing neurodegeneration and neuroprotection in the human central nervous system |
ATE418346T1 (de) * | 2004-04-08 | 2009-01-15 | Sangamo Biosciences Inc | Zusammensetzungen zur behandlung von neuropathischen und neurodegenerativen erkrankungen |
WO2007001332A2 (en) * | 2004-08-04 | 2007-01-04 | University Of Massachusetts | Anti-pathogen immunoadhesins |
CA2604515A1 (en) | 2005-04-18 | 2006-10-26 | The Provost, Fellows And Scholars Of The College Of The Holy And Undivid Ed Trinity Of Queen Elizabeth, Near Dublin | Toll-like receptor 14 (tlr14 ) and use thereof |
US20070275416A1 (en) * | 2006-05-16 | 2007-11-29 | Gsf-Forschungszentrum Fuer Umwelt Und Gesundheit Gmbh | Affinity marker for purification of proteins |
JP5554703B2 (ja) * | 2007-06-28 | 2014-07-23 | オプソナ セラピューティクス リミテッド | 自己免疫疾患の治療のための組成物および方法 |
WO2009090493A2 (en) * | 2007-12-06 | 2009-07-23 | Korea Advanced Institute Of Science And Technology | Tlr4 decoy receptor protein |
CA2737549A1 (en) * | 2008-09-16 | 2010-03-25 | Luke Anthony John O'neill | Compositions and methods for modulating toll-like receptor activity |
JP2012504651A (ja) * | 2008-10-02 | 2012-02-23 | ヤンセン バイオテツク,インコーポレーテツド | Toll様受容体の活性を抑制するための方法 |
WO2012016973A1 (en) * | 2010-08-02 | 2012-02-09 | Transmit Gmbh | Invention related to contact allergens |
BR112014000055A2 (pt) * | 2011-07-01 | 2017-06-13 | Bayer Ip Gmbh | polipeptídeos de fusão de relaxina e usos dos mesmos |
US10030067B2 (en) | 2013-03-15 | 2018-07-24 | University Of Florida Research Foundation, Incorporated | Compounds for treating neurodegenerative proteinopathies |
-
2014
- 2014-03-14 US US14/775,302 patent/US10030067B2/en active Active
- 2014-03-14 WO PCT/US2014/029202 patent/WO2014144686A1/en active Application Filing
- 2014-03-14 CA CA2942514A patent/CA2942514A1/en not_active Abandoned
- 2014-03-14 AU AU2014228886A patent/AU2014228886B2/en not_active Ceased
- 2014-03-14 EP EP14764448.8A patent/EP2970428A4/en not_active Withdrawn
- 2014-03-14 JP JP2016503012A patent/JP2016516053A/ja active Pending
-
2016
- 2016-07-20 HK HK16108680.0A patent/HK1220699A1/zh unknown
-
2018
- 2018-06-19 US US16/011,728 patent/US11345738B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
AU2014228886A1 (en) | 2015-10-29 |
AU2014228886B2 (en) | 2018-11-29 |
US20180355018A1 (en) | 2018-12-13 |
US11345738B2 (en) | 2022-05-31 |
EP2970428A1 (en) | 2016-01-20 |
JP2016516053A (ja) | 2016-06-02 |
US10030067B2 (en) | 2018-07-24 |
EP2970428A4 (en) | 2016-08-31 |
US20160024178A1 (en) | 2016-01-28 |
CA2942514A1 (en) | 2014-09-18 |
WO2014144686A1 (en) | 2014-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201604643B (en) | Hydroformylation process | |
HK1220155A1 (zh) | 治療癌症的方法 | |
SG11201603050TA (en) | Methods for treating cancers | |
GB201312991D0 (en) | Process | |
GB201307334D0 (en) | Process | |
PL3049383T3 (pl) | Sposób hydroformylowania | |
GB201321440D0 (en) | Process | |
IL245037B (en) | Treatment for pancreatic cancer | |
HK1220699A1 (zh) | 治療神經退行性蛋白質病的化合物 | |
GB201322454D0 (en) | Process | |
GB201316269D0 (en) | Process | |
IL245541A0 (en) | New methods for the treatment of neurodegenerative diseases | |
GB201401963D0 (en) | Process | |
GB201321611D0 (en) | Process | |
GB201318888D0 (en) | Process | |
GB201321627D0 (en) | Process | |
LT3016682T (lt) | Vėžio gydymo būdai | |
GB201401922D0 (en) | Process | |
GB201322273D0 (en) | Process | |
GB201314334D0 (en) | Process | |
GB201302441D0 (en) | Process | |
GB201415000D0 (en) | Improved process | |
GB201320869D0 (en) | Process | |
GB201307327D0 (en) | Process | |
GB201300073D0 (en) | Process |